<div id=toc></div>

# Table of Contents

- [q-bio.QM](#q-bio.QM) [Total: 3]
- [cs.AI](#cs.AI) [Total: 1]


<div id='q-bio.QM'></div>

# q-bio.QM [[Back]](#toc)

### [1] [Integrating Color Histogram Analysis and Convolutional Neural Network for Skin Lesion Classification](https://arxiv.org/abs/2601.20869)
*M. A. Rasel,Sameem Abdul Kareem,Unaizah Obaidellah*

Main category: q-bio.QM

TL;DR: 提出基于颜色数量的皮肤病变分析新特征，使用CNN分类病变颜色数量，在三个公开数据集上验证，最佳模型F1分数75%


<details>
  <summary>Details</summary>
Motivation: 皮肤病变颜色是诊断黑色素瘤等皮肤疾病的重要特征，但现有方法未充分利用颜色数量这一特征。颜色数量可以指示疾病严重程度，帮助区分恶性黑色素瘤和良性病变。

Method: 1. 提出颜色直方图分析方法，从PH2、ISIC2016和Med Node三个数据集中提取病变像素值；2. 基于PH2的真实标注，通过颜色直方图分析估计其他数据集的真实颜色数量；3. 设计并训练19层带残差跳跃连接的CNN，将病变按颜色数量分为三类；4. 使用DeepDream可视化网络学习特征，测试多种CNN配置；5. 应用LIME识别影响模型决策的重要区域。

Result: 最佳模型达到加权F1分数75%。LIME分析显示模型决策受特定区域影响。结果表明病变颜色数量是描述皮肤状况的重要特征，提出的带三个跳跃连接的CNN在临床诊断支持方面具有强大潜力。

Conclusion: 病变颜色数量是皮肤病变分析的重要特征，提出的CNN方法能有效分类病变颜色数量，为临床诊断提供有价值的支持工具。颜色数量特征结合深度学习模型在皮肤病变诊断中具有应用前景。

Abstract: The color of skin lesions is an important diagnostic feature for identifying malignant melanoma and other skin diseases. Typical colors associated with melanocytic lesions include tan, brown, black, red, white, and blue gray. This study introduces a novel feature: the number of colors present in a lesion, which can indicate the severity of disease and help distinguish melanomas from benign lesions. We propose a color histogram analysis method to examine lesion pixel values from three publicly available datasets: PH2, ISIC2016, and Med Node. The PH2 dataset contains ground truth annotations of lesion colors, while ISIC2016 and Med Node do not; our algorithm estimates the ground truth using color histogram analysis based on PH2. We then design and train a 19 layer Convolutional Neural Network (CNN) with residual skip connections to classify lesions into three categories based on the number of colors present. DeepDream visualization is used to interpret features learned by the network, and multiple CNN configurations are tested. The best model achieves a weighted F1 score of 75 percent. LIME is applied to identify important regions influencing model decisions. The results show that the number of colors in a lesion is a significant feature for describing skin conditions, and the proposed CNN with three skip connections demonstrates strong potential for clinical diagnostic support.

</details>


### [2] [Log Focal Frequency Loss for Bioimage Restoration](https://arxiv.org/abs/2601.20878)
*Xingjian Zhang,Claire Leclech,Louison Blivet-Bailly,Abdul I. Barakat,Elsa D. Angelini*

Main category: q-bio.QM

TL;DR: 提出针对显微镜图像恢复的对数焦点频率损失(LFFL)，结合对数感知原理，在荧光细胞核去模糊和斑马鱼胚胎去噪任务中优于现有方法


<details>
  <summary>Details</summary>
Motivation: 显微镜图像恢复面临独特挑战：需要保护精细纹理和锐利边缘，同时处理大动态范围和空间对比度变化的关键稀疏结构。现有GAN方法中的频率域损失主要针对自然图像设计，不适用于显微镜图像的特殊需求。

Method: 提出对数焦点频率损失(LFFL)，基于人类视觉的对数感知原理，结合对数空间差异的自适应频谱加权和对数阻尼误差测量，确保所有频带的平衡重建，同时保持结构连贯性和精细细节。

Result: 在荧光细胞核去模糊和斑马鱼胚胎去噪两个真实数据集上测试，相比仅使用空间域损失和现有频率域损失的方法，在多个质量指标上均有改进。

Conclusion: 针对显微镜图像恢复设计的对数焦点频率损失(LFFL)能有效处理大动态范围和稀疏结构，在保持结构连贯性和精细细节方面优于现有方法，代码已开源。

Abstract: Image restoration of biological structures in microscopy poses unique challenges for preserving fine textures and sharp edges. While recent GAN-based image restoration formulations have introduced frequency-domain losses for natural images, microscopy images pose distinct challenges with large dynamic ranges and sparse but critical structures with spatially-variable contrast. Inspired by the principle of logarithmic perception in human vision, we propose a log focal frequency loss (LFFL) tailored for microscopy restoration. This loss combines adaptive spectral weighting from log-space differences with log-dampened error measurement, ensuring balanced reconstruction across all frequency bands while preserving both structural coherence and fine details. We tested our GAN-based framework on two use-cases with real ground-truths: deblurring of fluorescence images of cell nuclei on microgroove substrates and denoising of zebrafish embryo images from the FMD dataset. Compared to training with only spatial-domain losses and with existing frequency-domain losses, our method achieves improvements across several quality metrics. Code is available at github.com/xjzhaang/log-focal-frequency-loss.

</details>


### [3] [ATTNSOM: Learning Cross-Isoform Attention for Cytochrome P450 Site-of-Metabolism](https://arxiv.org/abs/2601.20891)
*Hajung Kim,Eunha Lee,Sohyun Chung,Jueon Park,Seungheun Baek,Jaewoo Kang*

Main category: q-bio.QM

TL;DR: ATTNSOM是一个用于预测细胞色素P450酶代谢位点的原子级框架，通过共享图编码器、分子条件原子表示和跨异构体注意力机制，整合分子固有反应性和跨异构体关系，在严重类别不平衡下改善代谢位点预测性能。


<details>
  <summary>Details</summary>
Motivation: 现有计算方法通常忽略P450异构体身份或独立建模异构体，未能充分捕捉跨异构体代谢模式，且评估指标主要依赖top-k度量，在严重类别不平衡下需要更直接的二元原子级判别指标。

Method: 提出ATTNSOM框架，结合共享图编码器、分子条件原子表示和跨注意力机制，整合分子固有反应性与跨异构体关系，捕捉P450异构体间的相关代谢模式。

Result: 在两个原子级标注的基准数据集上，模型在多个P450异构体上均取得一致的强top-k性能，相比消融变体获得更高的马修斯相关系数，表明对真实代谢位点的判别能力有所改善。

Conclusion: 结果支持显式建模跨异构体关系对代谢位点预测的重要性，代码和数据集已开源。

Abstract: Identifying metabolic sites where cytochrome P450 enzymes metabolize small-molecule drugs is essential for drug discovery. Although existing computational approaches have been proposed for site-of-metabolism prediction, they typically ignore cytochrome P450 isoform identity or model isoforms independently, thereby failing to fully capture inherent cross-isoform metabolic patterns. In addition, prior evaluations often rely on top-k metrics, where false positive atoms may be included among the top predictions, underscoring the need for complementary metrics that more directly assess binary atom-level discrimination under severe class imbalance. We propose ATTNSOM, an atom-level site-of-metabolism prediction framework that integrates intrinsic molecular reactivity with cross-isoform relationships. The model combines a shared graph encoder, molecule-conditioned atom representations, and a cross-attention mechanism to capture correlated metabolic patterns across cytochrome P450 isoforms. The model is evaluated on two benchmark datasets annotated with site-of-metabolism labels at atom resolution. Across these benchmarks, the model achieves consistently strong top-k performance across multiple cytochrome P450 isoforms. Relative to ablated variants, the model yields higher Matthews correlation coefficient, indicating improved discrimination of true metabolic sites. These results support the importance of explicitly modeling cross-isoform relationships for site-of-metabolism prediction. The code and datasets are available at https://github.com/dmis-lab/ATTNSOM.

</details>


<div id='cs.AI'></div>

# cs.AI [[Back]](#toc)

### [4] [The Patient is not a Moving Document: A World Model Training Paradigm for Longitudinal EHR](https://arxiv.org/abs/2601.22128)
*Irsyad Adam,Zekai Chen,David Laprade,Shaun Porwal,David Laub,Erik Reinertsen,Arda Pekis,Kevin Brown*

Main category: cs.AI

TL;DR: SMB-Structure：一种用于结构化电子健康记录的世界模型，结合联合嵌入预测架构和下一个标记预测，能够模拟患者动态而非仅预测标记


<details>
  <summary>Details</summary>
Motivation: 现有基于下一个标记预测的LLMs将患者视为需要总结的文档，而非需要模拟的动态系统。患者轨迹是状态在干预和时间作用下的演化，需要能够模拟动态而非仅预测标记的模型

Method: 提出SMB-Structure模型，结合联合嵌入预测架构和下一个标记预测。JEPA在潜在空间中从初始患者表示预测未来状态，而SFT在标记空间中重建未来患者状态，迫使轨迹动态在观察到下一个状态之前就被编码

Result: 在两个大规模队列（MSK癌症患者和INSPECT肺栓塞患者）上验证，线性探针评估显示该训练范式学习的嵌入能捕捉自回归基线无法恢复的疾病动态，在高度异质性患者群体的复杂任务上表现优异

Conclusion: SMB-Structure通过结合JEPA和SFT，能够有效模拟患者动态，为临床基础模型提供了新的范式，模型权重已开源

Abstract: Large language models (LLMs) trained with next-word-prediction have achieved success as clinical foundation models. Representations from these language backbones yield strong linear probe performance across biomedical tasks, suggesting that patient semantics emerge from next-token prediction at scale. However, this paradigm treats patients as a document to be summarized rather than a dynamical system to be simulated; a patient's trajectory emerges from their state evolving under interventions and time, requiring models that simulate dynamics rather than predict tokens. To address this, we introduce SMB-Structure, a world model for structured EHR that grounds a joint-embedding prediction architecture (JEPA) with next-token prediction (SFT). SFT grounds our model to reconstruct future patient states in token space, while JEPA predicts those futures in latent space from the initial patient representation alone, forcing trajectory dynamics to be encoded before the next state is observed. We validate across two large-scale cohorts: Memorial Sloan Kettering (23,319 oncology patients; 323,000+ patient-years) and INSPECT (19,402 pulmonary embolism patients). Using a linear probe evaluated at multiple points along the disease trajectory, we demonstrate that our training paradigm learns embeddings that capture disease dynamics not recoverable by autoregressive baselines, enabling SMB-Structure to achieve competitive performance on complex tasks characterized by high patient heterogeneity. Model weights are available at https://huggingface.co/standardmodelbio/SMB-v1-1.7B-Structure.

</details>
